View Author

Becker, M.J.

(Martin Becker)


patient amphotericin treatment liposomal amphotericin b study amphotericin b liposomal ambisome inhalation infection blood concentration disease group aspergillosi elisa model detection therapy sample method result fungizone serum inoculation animal survival lesion bal fluid antifungal galactomannan inhalation therapy placebo day 1 erasmus university rotterdam gm detection ambisome monotherapy assay chemotherapy culture chitin antifungal treatment efficacy addition aspergillu fluid sensitivity episode sandwich elisa increase mortality rat model regimen difference monotherapy parameter .... combination therapy effect control rotterdam placebo group antimicrobial agents table galactomannan detection day 7 gm concentrations 0.2 ml analysis buffer neutropenic reduction pellet einsele incidence sandwich antimicrobial treatment groups 28 days microbiol




3 Most Recent Publications

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: A randomized, placebo-controlled trial (Article)
Rijnders, B.J.A. Cornelissen, J.J. Marie, S. de Slobbe, L. Becker, M.J. Doorduijn, J.K. Hop, W.C.J. Ruijgrok, E.J. Löwenberg, B. Vulto, A.G. Lugtenburg, P.J.
2008-05-01
Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response (Article)
Becker, M.J. Marie, S. de Fens, M.H. Hop, W.C.J. Verbrugh, H.A. Bakker-Woudenberg, I.A.J.M.
2002-01-01
Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model (Article)
Becker, M.J. Marie, S. de Willemse, D. Verbrugh, H.A. Bakker-Woudenberg, I.A.J.M.
2000-01-01